Patents by Inventor Su Youn Nam

Su Youn Nam has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9663495
    Abstract: Provided is a triazolone derivative or its pharmaceutically acceptable salt, a process for the preparation thereof, and a pharmaceutical composition comprising the same. The triazolone derivative or its pharmaceutically acceptable salt can effectively activate GPR119; and therefore be usefully applied for preventing or treating diabetes mellitus.
    Type: Grant
    Filed: April 22, 2014
    Date of Patent: May 30, 2017
    Assignee: YUHAN CORPORATION
    Inventors: Tae-Dong Han, Eun-Hye Jung, Chung-Ho Yi, Byoung-Moon Lee, Yoo-Hoi Park, Dong-Hoon Lee, Jong-Ho Kang, Na-Yeon Yang, Do-Hoon Kim, Kwan-Hoon Hyun, Kaap-Joo Park, Chun-Ho Lee, Su-Youn Nam
  • Patent number: 9493478
    Abstract: The present invention provides a fused ring compound containing furan or a pharmaceutically acceptable salt thereof, a method for preparing same, a pharmaceutical composition comprising same, and a use thereof. The fused ring compound containing furan or a pharmaceutically acceptable salt thereof inhibits the activity of phosphatidylinositol 3-kinase (PI3K) and can therefore be used in a pharmaceutical composition for treating and preventing respiratory diseases, inflammatory diseases, proliferative diseases, cardiovascular diseases, or central nervous system diseases which occur due to the over-activation of PI3K.
    Type: Grant
    Filed: July 23, 2013
    Date of Patent: November 15, 2016
    Assignee: YUHAN CORPORATION
    Inventors: Hyoung Sig Seo, Tae Kyun Kim, Hyun Joo Lee, Dong Hoon Kim, Gyu Jin Lee, Jun Chul Park, Ji Yeong Gal, Tae-hoon Kim, Kwan Hoon Hyun, Kyoung Kyu Ahn, Kaapjoo Park, Su Youn Nam, Ge Hyeong Lee, Hee Jong Lim
  • Publication number: 20160068515
    Abstract: Provided is a triazolone derivative or its pharmaceutically acceptable salt, a process for the preparation thereof, and a pharmaceutical composition comprising the same. The triazolone derivative or its pharmaceutically acceptable salt can effectively activate GPR119; and therefore be usefully applied for preventing or treating diabetes mellitus.
    Type: Application
    Filed: April 22, 2014
    Publication date: March 10, 2016
    Applicant: YUHAN CORPORATION
    Inventors: Tae-Dong HAN, Eun-Hye JUNG, Chung-Ho YI, Byoung-Moon LEE, Yoo-Hoi PARK, Dong-Hoon LEE, Jong-Ho KANG, Na-Yeon YANG, Do-Hoon KIM, Kwan-Hoon HYUN, Kaap-Joo PARK, Chun-Ho LEE, Su-Youn NAM
  • Publication number: 20150191478
    Abstract: The present invention provides a fused ring compound containing furan or a pharmaceutically acceptable salt thereof, a method for preparing same, a pharmaceutical composition comprising same, and a use thereof. The fused ring compound containing furan or a pharmaceutically acceptable salt thereof inhibits the activity of phosphatidylinositol 3-kinase (PI3K) and can therefore be used in a pharmaceutical composition for treating and preventing respiratory diseases, inflammatory diseases, proliferative diseases, cardiovascular diseases, or central nervous system diseases which occur due to the over-activation of PI3K.
    Type: Application
    Filed: July 23, 2013
    Publication date: July 9, 2015
    Applicant: YUHAN CORPORATION
    Inventors: Hyoung Sig Seo, Tae Kyun Kim, Hyun Joo Lee, Dong Hoon Kim, Gyu Jin Lee, Jun Chul Park, Ji Yeong Gal, Tae-hoon Kim, Kwan Hoon Hyun, Kyoung Kyu Ahn, Kaapjoo Park, Su Youn Nam, Ge Hyeong Lee, Hee Jong Lim